Natixis Advisors
AMAG

Natixis Advisors’s AMAG Pharmaceuticals AMAG Stock Holding History

Natixis Advisors’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-71,549
Closed -$2.84M – 1031
2015
Q3 		$2.84M Buy
71,549
+15,380
+27% +$955K 0.05% 517
2015
Q2 		$3.88M Buy
56,169
+166
+0.3% +$10.4K 0.07% 431
2015
Q1 		$3.06M Sell
56,003
-746
-1% -$35.6K 0.05% 514
2014
Q4 		$2.42M Buy
+56,749
New +$2.05M 0.05% 545

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Natixis Advisors's AMAG Position: Q4 2015 in Review

Natixis Advisors sold out of AMAG Pharmaceuticals (AMAG) in Q4 2015, closing a stake of 71,549 shares — an estimated $2.84M sold.

Natixis Advisors first reported a position in AMAG in Q4 2014 and held it in 4 quarters. The position peaked at $3.88M in Q2 2015. 172 funds tracked by Wall St. Rank hold AMAG as of Q4 2015.

  • Natixis Advisors reported no remaining AMAG Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Natixis Advisors sold 71,549 AMAG Pharmaceuticals shares in Q4 2015, an estimated $2.84M.
  • Natixis Advisors first reported a position in AMAG Pharmaceuticals in Q4 2014 and held it in 4 quarters.
  • Natixis Advisors's AMAG Pharmaceuticals position peaked at $3.88M in Q2 2015.
  • 172 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2015.

Based on Natixis Advisors's 13F filing for Q4 2015, filed 12 Feb 2016.